Alex Chenchik — ASN Events
  1. Schedule
  2. Alex Chenchik

Alex Chenchik

Cellecta Inc., USA, United States

  • This delegate is presenting an abstract at this event.
Dr. Alex Chenchik, president and chief scientific officer of Cellecta, Inc. founded the company in 2006. Cellecta is focused on the development and application of next-generation functional genomic and other technologies for biomarker and drug target discovery and validation. Dr. Chenchik received his doctorate in Molecular Biology from the Institute of Molecular Biology, Moscow, Russia. He has authored over 50 publications and holds 15 issued patents.
Presentations this author is a contributor to:

A practical guide for adaptive immune receptor repertoire profiling and the characterization of antigen-induced clonotypes with applications in vaccine development, autoimmunity, and cancer (#22)

11:45 AM
Alex Chenchik
Session 6: Adaptive Immunity (Concurrent Session)